Hi Bedger,
We must be on the cards for a EUA possibly a full approval.
You can not ignore the reduction in mortality in the ARDS trial.
Plus this is a global problem.
Novartis would be throwing everything they have to persuade
the FDA. The NIH who tipped in $50 mill would be keen on some
approvals as well.
Aloha.
Ann: COVID ARDS Trial Topline 60-Day Results, page-1517
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |